about
Focus on adoptive T cell transfer trials in melanomaTailoring the Treatment of Melanoma: Implications for Personalized MedicineNanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewGenetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.A brief history of melanoma: from mummies to mutationsPhase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanomaPathogenesis, diagnosis and management of primary melanoma of the colon.A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses.Pancreatic resection for metastatic melanoma. Case report and review of the literature.Rationale for complete metastasectomy in patients with stage IV metastatic melanoma.Primary colonic melanoma presenting as ileocecal intussusception: case report and literature review.Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model.Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers.Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival
P2860
Q21328679-0537C1D1-F157-48E7-84CE-07D5DFAF4D3AQ26775806-2BBF9ACF-9498-4BE8-AFF3-3EED6B85A035Q28394719-498A3EEA-F95E-49AA-868F-4AD3B81CD32EQ33350614-B2D0AECA-09A9-4410-9671-111ADA6834E5Q34259205-B5BF9FE9-145B-4FA9-9F5D-6CBF00DA8ADDQ34372972-1D8D34CF-DC71-47E0-8799-2BFF8F82A77FQ34581251-003E8198-B315-47E0-9339-6E5F859B054AQ35751850-DCB66A38-44B0-459F-A853-AE464F188D82Q37577095-59F20B75-7452-4F74-9796-9D522D2DB05AQ37762752-B011CD8D-A215-4B0B-A2A4-73626E4020EFQ37920840-4DA27B57-378B-4F21-84B6-8238DEA43B5FQ38234879-BB3A1A83-3CC8-449E-BA88-A57D7A92443FQ39531146-F3330639-749C-4147-A46C-155D0D9AAC18Q48133872-AC500333-B117-460F-BF22-4D92F81C16EEQ58211548-F3C5C297-CEFA-4D11-8A7E-10353D017E45
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The history and future of chemotherapy for melanoma.
@ast
The history and future of chemotherapy for melanoma.
@en
The history and future of chemotherapy for melanoma.
@nl
type
label
The history and future of chemotherapy for melanoma.
@ast
The history and future of chemotherapy for melanoma.
@en
The history and future of chemotherapy for melanoma.
@nl
prefLabel
The history and future of chemotherapy for melanoma.
@ast
The history and future of chemotherapy for melanoma.
@en
The history and future of chemotherapy for melanoma.
@nl
P2860
P1476
The history and future of chemotherapy for melanoma.
@en
P2093
Arvin S Yang
Paul B Chapman
P2860
P304
P356
10.1016/J.HOC.2009.03.006
P577
2009-06-01T00:00:00Z